These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


183 related items for PubMed ID: 7671252

  • 1. Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model.
    Velders MP, van Rhijn CM, Briaire IH, Fleuren GJ, Warnaar SO, Litvinov SV.
    Cancer Res; 1995 Oct 01; 55(19):4398-403. PubMed ID: 7671252
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J, Andersson H, Bäck T, Hultborn R, Jensen H, Karlsson B, Lindegren S, Palm S, Warnhammar E, Jacobsson L.
    J Nucl Med; 2005 Nov 01; 46(11):1907-15. PubMed ID: 16269606
    [Abstract] [Full Text] [Related]

  • 5. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF, Sutton VR, Li W, Burgess J, McKEnzie IF, Pietersz GA, Trapani JA.
    Cancer Res; 1994 Dec 01; 54(23):6160-6. PubMed ID: 7954462
    [Abstract] [Full Text] [Related]

  • 6. Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation model.
    Vuist WM, v Buitenen F, de Rie MA, Hekman A, Rümke P, Melief CJ.
    Cancer Res; 1989 Jul 15; 49(14):3783-8. PubMed ID: 2472198
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 9. Local administration of monoclonal antibody-drug conjugate: a new strategy to reduce the local recurrence of colorectal cancer.
    Kitamura K, Takahashi T, Kotani T, Miyagaki T, Yamaoka N, Tsurumi H, Noguchi A, Yamaguchi T.
    Cancer Res; 1992 Nov 15; 52(22):6323-8. PubMed ID: 1423277
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.
    Fan Z, Baselga J, Masui H, Mendelsohn J.
    Cancer Res; 1993 Oct 01; 53(19):4637-42. PubMed ID: 8402640
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Immunoscintigraphy of anti-type IV collagenase monoclonal antibody in nude mice bearing human lung cancer xenograft].
    Dai Y, Jia B, Wang F, Du J, Shang BY, Zhen YS.
    Ai Zheng; 2003 Dec 01; 22(12):1243-8. PubMed ID: 14693044
    [Abstract] [Full Text] [Related]

  • 14. Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model.
    Hooijberg E, van den Berk PC, Sein JJ, Wijdenes J, Hart AA, de Boer RW, Melief CJ, Hekman A.
    Cancer Res; 1995 Feb 15; 55(4):840-6. PubMed ID: 7531616
    [Abstract] [Full Text] [Related]

  • 15. Radioimmunotherapy of human colorectal carcinoma xenografts using 90Y-labeled monoclonal antibody CO17-1A prepared by two bifunctional chelate techniques.
    Lee YC, Washburn LC, Sun TT, Byrd BL, Crook JE, Holloway EC, Steplewski Z.
    Cancer Res; 1990 Aug 01; 50(15):4546-51. PubMed ID: 2164441
    [Abstract] [Full Text] [Related]

  • 16. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
    Shockley TR, Lin K, Sung C, Nagy JA, Tompkins RG, Dedrick RL, Dvorak HF, Yarmush ML.
    Cancer Res; 1992 Jan 15; 52(2):357-66. PubMed ID: 1728407
    [Abstract] [Full Text] [Related]

  • 17. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

  • 18. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A, Khazaeli MB, Safavy K, Mayo MS, Buchsbaum DJ.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [Abstract] [Full Text] [Related]

  • 19. The role of monoclonal antibody affinity in tumor immunotherapy evaluated in in vivo models for minimal residual disease.
    Velders MP, van Rhijn CM, Cornelissen IM, van Muijen GN, Briaire IH, Dohlsten M, Fleuren GJ, Warnaar SO, Litvinov SV.
    J Immunother Emphasis Tumor Immunol; 1996 Jul 15; 19(4):245-56. PubMed ID: 8877719
    [Abstract] [Full Text] [Related]

  • 20. Penetration and binding of antibodies in experimental human solid tumors grown in mice.
    Ong GL, Mattes MJ.
    Cancer Res; 1989 Aug 01; 49(15):4264-73. PubMed ID: 2743313
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.